Lyumjev - A New Insulin Lispro for Diabetes

Date: October 19, 2020 Issue #:  1609Summary:  The FDA has approved insulin lispro-aabc (Lyumjev– Lilly), a faster-acting formulation of insulin lispro(Humalog), for treatment of type 1 and type 2 diabetes in adults.Fiasp, a faster-acting formulation of insulin aspart(Novolog), was approved in 2017.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Source Type: research